Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$58.69 - $80.46 $8,216 - $11,264
-140 Closed
0 $0
Q1 2018

May 01, 2018

BUY
$52.72 - $67.25 $4,217 - $5,380
80 Added 133.33%
140 $9,000
Q4 2017

Feb 06, 2018

SELL
$58.2 - $72.76 $3,259 - $4,074
-56 Reduced 48.28%
60 $4,000
Q3 2017

Nov 03, 2017

BUY
$57.01 - $118.75 $6,613 - $13,775
116
116 $7,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Alpha Omega Wealth Management LLC Portfolio

Follow Alpha Omega Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Omega Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Omega Wealth Management LLC with notifications on news.